Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

During the Trading Day
155.72 +1.74 / +1.13%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
157.50 +1.78 / +1.14%
 
Volume: 105.5K

Today’s Trading

Previous close153.98
Today’s open154.91
Day’s range151.36 - 157.10
Volume4,910,546
Average volume (3 months)3,508,715
Market cap$116.8B
Dividend yield2.03%
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+12.00%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.30%
P/E ratio20.6
Price/Sales6.12
Price/Book4.54

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+1.03+0.96%
BIIBBiogen+6.24+2.09%
BXLTBaxalta Inc+0.98+2.76%
BAXBaxter International...+0.92+2.44%
Data as of 4:04pm ET, 08/27/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)$2.37
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers